PTC Therapeutics Inc
F:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
F:BH3
|
US |
|
A
|
Adidas AG
XMUN:ADS
|
DE |
|
K
|
Kawasaki Kisen Kaisha Ltd
DUS:KLI1
|
JP |
|
P
|
Pilgrims Pride Corp
F:6PP
|
US |
|
B
|
Bank of China Ltd
XMUN:W8V
|
CN |
|
E
|
Everest Group Ltd
DUS:ERE
|
BM |
|
Z
|
Zurich Insurance Group AG
XMUN:ZFIN
|
CH |
|
3
|
3M Co
F:MMM
|
US |
|
T
|
TE Connectivity Ltd
BMV:TELN
|
CH |
|
Alnylam Pharmaceuticals Inc
LSE:0HD2
|
US |
|
B
|
Badger Meter Inc
SWB:33B
|
US |
|
SoFi Technologies Inc
F:6B0
|
US |
|
P
|
PetroChina Co Ltd
F:PC6A
|
CN |
Shareholder Yield
Current shareholder yield for 
BH3 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BH3 Price
PTC Therapeutics Inc
| Average Annual Return | 13.5% |
| Standard Deviation of Annual Returns | 45.24% |
| Max Drawdown | -70% |
| Market Capitalization | 6B EUR |
| Shares Outstanding | 76 700 000 |
| Percentage of Shares Shorted |
N/A
|
